* iSpecimen Inc ISPC.OQ ISPC.O is expected to show a
rise in
quarterly revenue when it reports results on August 2.
* The Lexington Massachusetts-based company is expected to
report
a 31.3% increase in revenue to $3.071 million from $2.34
million a year ago, according to the estimate from one analyst,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for iSpecimen Inc is
for a
loss of 30 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for iSpecimen
Inc is
$6.5, above its last closing price of $1.69.
This summary was machine generated July 31 at 14:10 GMT. All
figures in US dollars unless otherwise stated